Acupressure's Impact on Pain and Physiological Parameters in Infants Undergoing Cardiac Catheterization
Launched by BASKENT UNIVERSITY · Dec 9, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how acupressure, a gentle technique where pressure is applied to specific points on the body, can help reduce pain and improve overall comfort in infants undergoing a procedure called cardiac catheterization. This procedure is often needed for infants with congenital heart disease. The trial aims to find out if acupressure can lower pain levels and help with the infants' physiological responses—like heart rate and blood pressure—during and after the procedure.
To participate, infants must be between 1 and 12 months old, have congenital heart disease, and be having their first cardiac catheterization. They should not have any complications or specific medical conditions that might interfere with the study. Parents who volunteer their infants for this trial can expect that acupressure will be applied before and after the procedure to see if it helps reduce pain and improve recovery. Importantly, this study will help determine if incorporating acupressure into care can make the experience easier for young patients and their families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infants between 1 month and 12 months
- • Infants with congenital heart disease
- • Infants undergoing cardiac catheterization for the first time
- • Infants undergoing planned cardiac catheterization
- • Infants without acupressure experience
- • Infants whose parents volunteered to participate in the study
- Exclusion Criteria:
- • Infants with complications during catheterization
- • Infants followed up in the intensive care unit after catheterization
- • Infants with any deformity or lesion in the acupressure area
- • Infants who have not received analgesics after catheterization
- • Infants who were not given analgesics within six hours before catheterization
- • Infants with neurodevelopmental disorders
- • Infants whose parents did not volunteer to participate in the study
About Baskent University
Baskent University is a distinguished academic and research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a strong emphasis on evidence-based medicine, the university collaborates with a network of healthcare professionals and researchers to design and implement rigorous clinical research that aims to improve patient outcomes. Baskent University is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its research initiatives while fostering a collaborative environment that promotes scientific discovery and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported